Delaware jury awards Merck biggest-ever patent award of $2.54bn

A Delaware jury has ordered Gilead Sciences to pay $2.54 billion in damages to Merck for infringing a patent related to hepatitis C treatment. It is the largest-ever patent damages award
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: